content: UNITED STATES
                         SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549
  
  
  
                                      FORM 8-K
  
                                   CURRENT REPORT
       Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  
  
  
  
        Date of Report (Date of earliest event reported): September 30, 2002
  
  
  
                                 IMMUNOMEDICS, INC.
               (Exact name of registrant as specified in its charter)
  
  
           Delaware                  0-12104                  61-1009366
       (State or other             (Commission               (IRS Employer
       jurisdiction of             File Number)            Identification No.)
        incorporation)
  
  
  
       300  American Road,  Morris Plains,  New Jersey            07950
          (Address of principalexecutive offices)               (zip code)
  
  
         Registrant's telephone number, including area code: (973) 605-8200
  
  
                                   Not applicable
            (Former name or former address, if changed since last report)
  
  <PAGE>
  
  Item 7.  Financial Statements and Exhibits.
  
  
  (c)      Exhibits
  
            99.1 Certification  Pursuant to Section 906 of the  Sarbanes-Oxley Act
                 of 2002  (Subsections (a) and (b) of Section 1350,  Chapter 63 of
                 Title 18, United States Code), dated September 30, 2002.
  
  Item 9.  Regulation FD Disclosure
  
       On September 30, 2002, the Registrant  filed its Annual Report on Form 10-K
  for the  fiscal  year  ended  June 30,  2002 with the  Securities  and  Exchange
  Commission.  In connection with the filing of the Form 10-K,  attached hereto as
  an exhibit are  certifications  of the Registrant's  Chief Executive Officer and
  Chief  Financial  Officer,  as required by 18 U.S.C.  Section  1350,  as adopted
  pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. These  certifications
  are being furnished  herewith solely to accompany the Form 10-K,  pursuant to 18
  U.S.C.  Section  1350,  are not being  filed for  purposes  of Section 18 of the
  Securities  Exchange Act of 1934, as amended,  and are not to be incorporated by
  reference into any of the Registrant's  filings with the Securities and Exchange
  Commission,   whether   filed  prior  to  or  after  the   furnishing  of  these
  certifications,  regardless of any general or specific incorporation language in
  any such filing.
  
  
  <PAGE>
  
                                     SIGNATURES
  
            Pursuant to the  requirements of the Securities  Exchange Act of 1934,
       the  Registrant  has duly  caused this report to be signed on its behalf by
       the undersigned hereunto duly authorized.
  
  
                                             IMMUNOMEDICS, INC.
  
  
  
  
       Date:  September 30, 2002              /s/ CYNTHIA L. SULLIVAN
                                             ------------------------------
                                             Cynthia L. Sullivan
                                             President and Chief Executive Officer
  
  
  
                                         3
  <PAGE>
  
  
                                    EXHIBIT INDEX
  
  Exhibit
  Number   Description
  -------  -----------
  99.1     Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
           (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18,
           United States Code), dated September 30, 2002.
  
  
  
  
                                         4
  
  <PAGE>
                                                                      Exhibit 99.1
  
                                    Certification
       Pursuant to Section 906 of the  Sarbanes-Oxley Act of 2002 (Subsections (a)
       and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
  
  Pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002 (Subsections (a) and
  (b) of Section 1350,  Chapter 63 of Title 18,  United States Code),  each of the
  undersigned  officers  of  Immunomedics,   Inc.,  a  Delaware  corporation  (the
  "Company"), does hereby certify, to such officer's knowledge, that:
  
  The Form 10-K for the year ended June 30, 2002 (the "Form  10-K") of the Company
  fully complies with the requirements of Section 13(a) or 15(d) of the Securities
  Exchange  Act of 1934,  and the  information  contained  in the Form 10-K fairly
  presents,  in all material  respects,  the  financial  condition  and results of
  operations of the Company.
  
  
  Dated:   September 30, 2002      /s/ Cynthia L. Sullivan
                                   ----------------------------------------
                                      Cynthia L. Sullivan
                                      President and Chief Executive Officer
  
  
  Dated:   September 30, 2002      /s/ Gerard G. Gorman
                                   ----------------------------------------
                                      Gerard G. Gorman
                                      Vice President, Finance and
                                      Chief Financial Officer
  
  The foregoing certification is being furnished solely pursuant to Section 906 of
  the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter
  63 of Title 18, United States Code) and is not being filed as part of a separate
  disclosure document.
  
  
                                         5
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "sept8k_2002.txt", "description": "FORM 8-K FIN STMTS & REG FD", "secsgml_size_bytes": 5281}]
metadata_filer: {"company-data": {"conformed-name": "IMMUNOMEDICS INC", "cik": "0000722830", "assigned-sic": "2835", "irs-number": "611009366", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-12104", "film-number": "02777347"}, "business-address": {"street1": "300 AMERICAN RD", "city": "MORRIS PLAINS", "state": "NJ", "zip": "07950", "phone": "9736058200"}, "mail-address": {"street1": "300 AMERICAN ROAD", "city": "MORRIS PLAINS", "state": "NJ", "zip": "07950"}}
text: UNITED STATES
                         SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549
  
                                      FORM 8-K
  
                                   CURRENT REPORT
       Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  
        Date of Report (Date of earliest event reported): September 30, 2002
  
                                 IMMUNOMEDICS, INC.
               (Exact name of registrant as specified in its charter)
  
           Delaware                  0-12104                  61-1009366
       (State or other             (Commission               (IRS Employer
       jurisdiction of             File Number)            Identification No.)
        incorporation)
  
       300  American Road,  Morris Plains,  New Jersey            07950
          (Address of principalexecutive offices)               (zip code)
  
         Registrant's telephone number, including area code: (973) 605-8200
  
                                   Not applicable
            (Former name or former address, if changed since last report)
  Item 7.  Financial Statements and Exhibits.
  
  (c)      Exhibits
  
            99.1 Certification  Pursuant to Section 906 of the  Sarbanes-Oxley Act
                 of 2002  (Subsections (a) and (b) of Section 1350,  Chapter 63 of
                 Title 18, United States Code), dated September 30, 2002.
  
  Item 9.  Regulation FD Disclosure
  
       On September 30, 2002, the Registrant  filed its Annual Report on Form 10-K
  for the  fiscal  year  ended  June 30,  2002 with the  Securities  and  Exchange
  Commission.  In connection with the filing of the Form 10-K,  attached hereto as
  an exhibit are  certifications  of the Registrant's  Chief Executive Officer and
  Chief  Financial  Officer,  as required by 18 U.S.C.  Section  1350,  as adopted
  pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. These  certifications
  are being furnished  herewith solely to accompany the Form 10-K,  pursuant to 18
  U.S.C.  Section  1350,  are not being  filed for  purposes  of Section 18 of the
  Securities  Exchange Act of 1934, as amended,  and are not to be incorporated by
  reference into any of the Registrant's  filings with the Securities and Exchange
  Commission,   whether   filed  prior  to  or  after  the   furnishing  of  these
  certifications,  regardless of any general or specific incorporation language in
  any such filing.
  SIGNATURES
  
            Pursuant to the  requirements of the Securities  Exchange Act of 1934,
       the  Registrant  has duly  caused this report to be signed on its behalf by
       the undersigned hereunto duly authorized.
  
                                             IMMUNOMEDICS, INC.
  
       Date:  September 30, 2002              /s/ CYNTHIA L. SULLIVAN
                                             ------------------------------
                                             Cynthia L. Sullivan
                                             President and Chief Executive Officer
  
                                         3
  EXHIBIT INDEX
  
  Exhibit
  Number   Description
  -------  -----------
  99.1     Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
           (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18,
           United States Code), dated September 30, 2002.
  
                                         4
  Exhibit 99.1
  
                                    Certification
       Pursuant to Section 906 of the  Sarbanes-Oxley Act of 2002 (Subsections (a)
       and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
  
  Pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002 (Subsections (a) and
  (b) of Section 1350,  Chapter 63 of Title 18,  United States Code),  each of the
  undersigned  officers  of  Immunomedics,   Inc.,  a  Delaware  corporation  (the
  "Company"), does hereby certify, to such officer's knowledge, that:
  
  The Form 10-K for the year ended June 30, 2002 (the "Form  10-K") of the Company
  fully complies with the requirements of Section 13(a) or 15(d) of the Securities
  Exchange  Act of 1934,  and the  information  contained  in the Form 10-K fairly
  presents,  in all material  respects,  the  financial  condition  and results of
  operations of the Company.
  
  Dated:   September 30, 2002      /s/ Cynthia L. Sullivan
                                   ----------------------------------------
                                      Cynthia L. Sullivan
                                      President and Chief Executive Officer
  
  Dated:   September 30, 2002      /s/ Gerard G. Gorman
                                   ----------------------------------------
                                      Gerard G. Gorman
                                      Vice President, Finance and
                                      Chief Financial Officer
  
  The foregoing certification is being furnished solely pursuant to Section 906 of
  the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter
  63 of Title 18, United States Code) and is not being filed as part of a separate
  disclosure document.
  
                                         5